Source: International Congress 2017 – PG12 Life-threatening pulmonary infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Schultz (Amsterdam, Netherlands). Biomarkers for clinical management. International Congress 2017 – PG12 Life-threatening pulmonary infections

Member's Comments

No comment yet.

Related content which might interest you: Biomarkers in clinical decision making Source: Annual Congress 2012 - PG10 An update on mesothelioma diagnostics and treatment Year: 2012 Biomarkers and personalised treatment Source: Annual Congress 2012 - MS6 Severe asthma: diagnosis and treatment Year: 2012 Management of sarcoidosis in clinical practice Source: Eur Respir Rev 2016; 25: 141-150 Year: 2016 Assessing the effect of medical therapy in COPD: from pathophysiology and biomarkers to clinical practice Source: Annual Congress 2009 - PG15 The complexity of COPD: assessment and advanced therapies Year: 2009 Emerging concepts in outcome assessment for COPD clinical trials Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease Year: 2007 Evaluation of serum inflammatory biomarkers as predictors of treatment outcome in pulmonary tuberculosis Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016 Bronchiectasis severity assessment tools to predict clinical outcomes in the Indian Bronchiectasis Registry Source: Virtual Congress 2021 – Bronchiectasis and pleural infection Year: 2021 Clinical features and acute management of COVID-19 in children Source: Eur Respir Monogr 2021; 94: 144-161 Year: 2021 Importance of admission biomarkers in prognostication of  patients with SARS-Cov-2 Source: Virtual Congress 2021 – COVID-19 and acute respiratory failure Year: 2021 Biomarkers for the management of severe asthma: a survey Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021 Clinical features and acute management of COVID-19 in adults Source: Eur Respir Monogr 2021; 94: 101-123 Year: 2021 Are biomarkers helpful in sepsis for risk assessment or clinical trials? Source: Annual Congress 2011 - Molecular biomarkers at the bedside of critically ill patients Year: 2011 Prognostic impact and clinical characteristics of Interstitial Pneumonia with Autoimmune features (IPAF) in a multidisciplinary setting Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019 Clinical diagnosis, monitoring and biomarkers in ILDs Source: ERS Course 2019 - Interstitial Lung Diseases Year: 2019 Clinical diagnosis, monitoring and biomarkers in ILDs Source: ERS Course 2016 Year: 2016 Clinical diagnosis, monitoring and biomarkers in ILDs Source: ERS Course 2019 - Interstitial Lung Diseases Year: 2018 Clinical diagnosis, monitoring and biomarkers in ILDs Source: ERS Courses: Interstitial Lung Diseases Year: 2019